Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Alexion Pharmaceuticals, Inc.
FDA Inspection
•Alexion Pharmaceuticals, Inc.•March 7, 2025

Alexion Pharmaceuticals, Inc. – FDA Inspection, Mar 7, 2025

Record Details

This FDA Inspection record concerns Alexion Pharmaceuticals, Inc., with an inspection on March 7, 2025, issued by the New England District Office, covering human drugs.

Company
Alexion Pharmaceuticals, Inc.
Inspection Date
March 7, 2025
Product Type
Human Drugs
Office
New England District Office
Person
  • Meredith L. Miller
View Company Profile

ID · 5fb2d391-dc92-43ec-a7a3-bbb58a161055

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1262947
FDA center
Human Drugs
Project area
Postmarketing Surveillance and Epidemiology: Human Drugs
Outcome
Form 483 issued, view the record

FDA Citations

1
  1. FD&C Act 505-1(f)(4)Failure to comply with REMS Implementation System

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Alexion Pharmaceuticals, Inc.

6
DateClassificationOfficeProject area
July 28, 2026Not classifiedNew England District Office
July 1, 2026Not classifiedNew England District Office
November 7, 2024VAINew England District OfficePostmarketing Surveillance and Epidemiology: Human Drugs
September 14, 2023NAICenter for Drug Evaluation and ResearchBioresearch Monitoring
June 30, 2023NAICenter for Drug Evaluation and ResearchBioresearch Monitoring
View all 6 other inspections on the company page
Other documents for Alexion Pharmaceuticals, Inc.
  • FDA Inspection 1330676 - 2026-07-28
  • FDA Inspection 1326206 - 2026-07-01
  • FDA Inspection 1254018 - 2024-11-07
  • FDA Inspection 1219061 - 2023-09-14
  • FDA Inspection 1218199 - 2023-06-30

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Alexion Pharmaceuticals, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.